Pretreatment platelet count improves the prognostic performance of the TNM staging system and aids in planning therapeutic regimens for nasopharyngeal carcinoma: a single-institutional study of 2,626 patients.

CONCLUSIONS: Pretreatment platelet count, when combined with TNM classification, is a useful indicator for metastasis and survival in patients with NPC. It may improve the predictive value of the TNM classification and help to identify patients likely to benefit from more aggressive therapeutic regimens. PMID: 25962816 [PubMed - in process]

http://www.ncbi.nlm.nih.gov/pubmed/25962816?dopt=Abstract

Source: Chinese Journal of Cancer - May 14, 2015 Category: Cancer & Oncology Tags: Chin J Cancer Source Type: research